Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein

EMBO Journal

Volumn 30, Issue 2, 2011, Pages 317-327

  Carr, Simon M ^a   Munro, Shonagh ^a   Kessler, Benedikt ^b   Oppermann, Udo ^c   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cdk; methylation; phosphorylation; pRb; Set7 9

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; LYSINE; METHYLTRANSFERASE; RETINOBLASTOMA PROTEIN; SERINE;

ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; GROWTH REGULATION; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

CELL CYCLE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASES; LYSINE; MASS SPECTROMETRY; METHYLATION; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; RETINOBLASTOMA PROTEIN;

EID: 78751629039     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.311     Document Type: Article

References (38)

1. Bandara LR, Adamczewski JP, Hunt T, La Thangue NB (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352: 249-251
2. Batycka M, Inglis NF, Cook K, Adam A, Fraser-Pitt D, Smith DG, Main L, Lubben A, Kessler BM (2006) Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. Rapid Commun Mass Spectrom 20: 2074-2080
3. Blais A, Dynlacht BD (2007) E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 19: 658-662
4. Botz J, Zerfass-Thorne K, Spitkovaky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A, Jansen-Durr P (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol 16: 3401-3409
5. Brown NR, Noble ME, Endicott JA, Johnson LN (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol 1: 438-443
6. Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB (2001) Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3: 667-674
7. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D (2004) Regulation of p53 activity through lysine methylation. Nature 432: 353-360
8. Classon M, Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2: 910-917
9. Connell-Crowley L, Harper JW, Goodrich DW (1997) Cyclin D1/ Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8: 287-301
10. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262
11. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174
12. Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF (2001) Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21: 4773-4784
13. Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J, Hunt DF, Funabiki H, Allis CD (2005) Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438: 1116-1122
14. Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25: 5220-5227
15. Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, La Thangue NB (2008) Arginine methylation regulates the p53 response. Nat Cell Biol 10: 1431-1439
16. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/ECdk2. EMBO J 15: 7060-7069
17. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES (2000) RB-dependent S-phase response to DNA damage.Mol Cell Biol 20: 7751-7763
18. Latham JA, Dent SY (2007) Cross-regulation of histone modifications. Nat Struct Mol Biol 14: 1017-1024
19. Macaluso M, Montanari M, Giordano A (2006) Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodelling enzymes. Oncogene 25: 5263-5267
20. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166
21. Markham D, Munro S, Soloway J, O'Connor DP, La Thangue NB (2006) DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep 7: 192-198
22. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849
23. Mittnacht S (1998) Control of pRB phosphorylation. Curr Opin Genet Dev 8: 21-27
24. Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13: 261-291
25. Munro S, Khaire N, Inche A, Carr S, La Thangue NB (2010) Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 29: 2357-2367
26. Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ (2004) Acetylation regulates the differentiation-specific functions of the retinoblastoma protein. EMBO J 23: 1609-1618
27. Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, Reinberg D (2002) Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16: 479-489
28. Raynaud FI, Whittaker SR, Fischer PM, McClue S, Walton MI, Barrie SE, Garrett MD, Rogers P, Clarke SJ, Kelland LR, Valenti M, Brunton L, Eccles S, Lane DP, Workman P (2005) In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202. Clin Cancer Res 11: 4875-4887
29. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689-3695
30. Stevens C, La Thangue NB (2003) E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412: 157-169
31. Takaki T, Fukasawa K, Suzuki-Takahashi I, Semba K, Kitagawa M, Taya Y, Hirai H (2005) Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. J Biochem 137: 381-386
32. Taylor GK, Goodlett DR (2005) Rules governing protein identification by mass spectrometry. Rapid Commun Mass Spectrom 19: 3420
33. Uchida C, Miwa S, Kitagawa K, Hattori T, Isobe T, Otani S, Oda T, Sugimura H, Kamijo T, Ookawa K, Yasuda H, Kitagawa M (2005) Enhanced Mdm2 activity inhibits pRB function via ubiquitindependent degradation. EMBO J 24: 160-169
34. van den Heuvel S, Dyson NJ (2008) Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9: 713-724
35. Vidal A, Koff A (2000) Cell-cycle inhibitors: three families united by a common cause. Gene 247: 1-15
36. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
37. Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM, Gamblin SJ, Xiao B (2002) Crystal structure and functional analysis of the histone methyltransferase SET7/9. Cell 111: 105-115
38. Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS, La Thangue NB (2008) DNA-damage response control of E2F7 and E2F8. EMBO Rep 9: 252-259